In line with this concept, in the present study, diabetic mice presented enhanced levels of IL-1β and TNF-α in the spinal cord, while MSC treatment inhibited this upregulation, in parallel with its effects on behavioral sensory neuropathy. The gene discussed is TNF; the disease is sensory peripheral neuropathy.